Still, our results indicate that automatically measured serum IL-6 is a useful biomarker in the prediction of the unfavorable course of AP in a setting of secondary care hospital, i.e., a place where most patients with AP are initially admitted. This evidence concerns the gene IL6 and alkaline phosphatase measurement.